Search Results for “FDA” – Page 165 – media

Bristol-Myers Squibb’s Opdivo Ensures a Lung Cancer Position

Bristol-Myers Squibb secured a standing in the small cell lung cancer domain making up for its slower growth in the non-small cell lung cancer market compared to its counterpart, Merck.
- Source: FiercePharma
- 1,209
- August 22, 2018
BMS cancer FDA New Approvals
Novel Imaging Technique to Diagnose Tuberculosis Within An Hour

Quick diagnosis and treatment monitoring are critical due to the emergence of multidrug resistance, especially in tuberculosis. Taking this fact into consideration, a research team from Stanford University School of Medicine developed an imaging technique to diagnose tuberculosis (TB) within an hour and monitor the effectiveness of treatments.
- Source: The Verdict
- 811
- August 21, 2018
digital health medtech Researches tuberculosis
GlaxoSmithKline, Seqirus roll out First flu Vaccines for Coming Season

Flu vaccine producing pharma giants plan to supply millions of additional doses produced using futuristic manufacturing processes instead of conventional egg-based procedures, as they ship their first doses of flu-vaccine for the impending season.
- Source: FiercePharma
- 728
- August 17, 2018
Company Insight flu shot vaccines
Pharmaceutical exports; how to approach marketing research

Identifying the right clients is a common challenge when it comes to product exporting issues. This is why well-organized marketing research which is precise and reliable can be the key to assist you to work out a clear working plan.
- Source: Ddu
- 1,198
- August 17, 2018
market research pharmaceutical Researches
Plunging HIV Infections Linked to Increased U.S. PrEP use

Pre-exposure prophylaxis (PrEP) by U.S. residents against HIV infection has resulted in positive outcomes. Incidence of new HIV infections among those 13 years old and above fell during 2012 - 2016, and this plunge presented a statistically noteworthy association with an increase in drug prophylaxis among U.S. residents in the same duration.
- Source: MDEdge
- 704
- August 11, 2018
HIV Researches
One Boy’s Struggle with Epilepsy Leads to First Marijuana-Derived Medicine

Epidiolex, compounded from decontaminated cannabidiol, or CBD, permitted for two atypical types of epilepsy, would be the first prescription medication extracted from the marijuana plant, expected to reach pharmacies this fall.
- Source: NPR
- 719
- August 9, 2018
FDA Medical marijuana New Approvals
Efficiency and Reliability of Clinical Laboratory & Analytical Equipment -The Medical Analyst and Truth Teller

In the medical field, no matter what kind of science or technological issue we are dealing with, laboratory equipment is essential for all researching, experimenting and measuring processes, hence, the efficiency and reliability of the laboratory equipment are to key the indexes we need to focus on.
- Source: Ddu
- 840
- August 7, 2018
medical device products Researches
Sun Pharma Launches Kapspargo Sprinkle to Treat Chest Pain & High Blood Pressure

Sun Pharma, India’s largest drugmaker, has launched Kapspargo Sprinkle in the US. This drug is used in the treatment of heart failure, chest pain, and high blood pressure.
- Source: MoneyControl
- 585
- August 7, 2018
beta blocker FDA New Approvals
Avatrombopag Reduced Procedure-Related Transfusions in Thrombocytopenia, Chronic Liver Disease Patients

Findings from two international, randomized, double-blind, phase III, placebo-controlled trials published in the September issue of Gastroenterology revealed that the oral second-generation thrombopoietin agonist avatrombopag (Doptelet) when given once a day, notably decreased the requirement for platelet transfusion...
- Source: MDEdge
- 934
- August 3, 2018
chronic liver disease Clinical Trials FDA
Aerie Extends Drug-Delivery Tech Contract with DSM Biomedical

The extended deal with DSM offers Aerie an elite worldwide license to DSM’s polyesteramide polymer technology for a limitless number of drugs in any ophthalmic indication and also an exposure to DSM’s preclinical latanoprost implant created for people with glaucoma. The two companies have spanned their partnership till the end of 2020, as per Aerie.
- Source: DrugDeliveryBusiness
- 1,002
- August 3, 2018
Company Insight digital health glaucoma pharmaceutical

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.